acts centrally to reduce appetite Setmelanotide : Reserved for specific genetic obesity syndromes (e.g., POMC/PCSK1/LEPR deficiency, Bardet-Biedl syndrome) under specialist supervision Non-pharmacological interventions form the cornerstone of weight management and may be particularly appropriate: Structured lifestyle programmes : NICE recommends multicomponent interventions including dietary modification, increased physical activity, and behavioural strategies
Therefore, medication selection should match each patients metabolism, health history, goals, and response pattern. Who may qualify for tirzepatide treatment
Stay hydrated: Drink plenty of water, especially if you experience nausea or diarrhea
Most individuals start to see results within a few weeks of beginning peptide therapy
Note that combining GLP-1/GIP receptor agonists with DPP-4 inhibitors is not recommended due to overlapping mechanisms
This happens when free radicals build up and damage your cells